<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>WORL | Justesen Carver | Activity</title>
	<link>https://www.worl.com/patchnode65/activity/</link>
	<atom:link href="https://www.worl.com/patchnode65/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Justesen Carver.</description>
	<lastBuildDate>Sat, 04 Jul 2026 16:13:57 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">0609946080ec4f6c2effceb7e45cd416</guid>
				<title>Justesen Carver posted an update: Anavar, also known by its chemical name oxandrolone, has [&#133;]</title>
				<link>https://www.worl.com/activity/p/16608/</link>
				<pubDate>Fri, 03 Oct 2025 18:03:51 +0000</pubDate>

									<content:encoded><![CDATA[<p>Anavar, also known by its chemical name oxandrolone, has gained popularity among bodybuilders and fitness enthusiasts for its reputation as a mild anabolic steroid that can aid in lean muscle gain while minimizing the risk of severe side effects. Despite this positive perception, there is still much confusion surrounding appropriate dosing&hellip;<span class="activity-read-more" id="activity-read-more-16608"><a href="https://www.worl.com/activity/p/16608/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">734698cb23fd69e36f21e5a816b38c5e</guid>
				<title>Justesen Carver became a registered member</title>
				<link>https://www.worl.com/activity/p/14880/</link>
				<pubDate>Thu, 02 Oct 2025 16:36:09 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>